Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last ¥6,070 JPY
Change Today -100.00 / -1.62%
Volume 730.8K
As of 1:51 AM 10/9/15 All times are local (Market data is delayed by at least 15 minutes).

sysmex corp (6869) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/18/15 - ¥8,640
52 Week Low
10/17/14 - ¥3,790
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SYSMEX CORP (6869)

Related News

No related news articles were found.

sysmex corp (6869) Related Businessweek News

No Related Businessweek News Found

sysmex corp (6869) Details

Sysmex Corporation, together with its subsidiaries, engages in the research and development, production, sale, service, and support of diagnostic instruments, reagents, and software worldwide. The company provides diagnostics products for use in the areas of hematology, hemostasis, immunochemistry, clinical chemistry, urinalysis, and others; and La-vietal LS, a clinical testing instrument system that links clinical testing instruments and other systems to provide an efficient operating environment. It also offers particle analyzer products, including FPIA-3000 Flow Particle Image Analyzer, which offers automated analysis of particle size and shape; FPIA-3000 Darkfield unit to analyze samples, such as drugs, mica, and biological cells; and XT-2000iV, an animal blood cell analysis software used in the hematological analysis of laboratory veterinary animals, such as rats, mice, or dogs. In addition, the company provides life sciences solutions comprising automated gene amplification detector, a system for the detection of lymph node metastasis based on the one-step nucleic acid amplification method used for the diagnosis of breast, colon, and stomach cancer lymph node diagnosis in hospitals and other facilities, as well as a laboratory testing service for research involving the risk of recurrence of breast cancer. Further, it offers ASTRIM FIT, a peripheral artery monitoring device that measures hemoglobin levels without blood sampling and is used in fitness centers and various other sites, as well as sells health management support software. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

5,903 Employees
Last Reported Date: 06/19/15
Founded in 1968

sysmex corp (6869) Top Compensated Officers

Chairman of the Managing Board, Chief Executi...
Total Annual Compensation: ¥250.0M
Compensation as of Fiscal Year 2015.

sysmex corp (6869) Key Developments

Sysmex Corporation to Open New R&D Open Innovation Lab

Sysmex Corporation announced that it plans to establish a new open innovation lab to accelerate R&D activities toward the realization of personalized medicine. The new lab will be located at Technopark (Nishiku, Kobe), Sysmex's hub for R&D. Within the healthcare domain, Sysmex is focused on the creation of leading edge, high value testing and diagnostic technologies centered on in vitro diagnostics. To accelerate R&D activities toward the realization of personalized medicine, Sysmex is now planning to establish an open innovation lab at Technopark, its R&D hub. In addition to employing Sysmex's proprietary technologies, the new lab will be equipped with ICTrelated equipment to promote bioinformatics, highly functional, highperformance testing equipment and an environment fostering open innovation to increase collaboration. Through interaction among researchers, Sysmex aims to promote the merging of ideas. Going forward, Sysmex will solicit participation from researchers around the world.

Sysmex Corporation to Expand U.S. Reagent Factory

Sysmex Corporation has decided to expand its U.S. reagent factory to meet future demand growth for reagents in the Americas. The Sysmex Group ensures a stable supply of reagents to its customers around the world by manufacturing reagents at two factories in Japan and seven factories in six countries overseas. In response to increasing sales and anticipated demand increases in the Americas, the company has also decided to upgrade and expand its reagent factory in the United States. The reagent factory, located in a northwest suburb of Chicago, Illinois, will increase its capacity by 1.6 times. The expansion also aims to expand the types of reagents produced, and to ensure manufacturing that is environmentally friendly, high quality, and efficient. Construction to expand the factory will be conducted in stages. The initial stage, which is scheduled to become operational in September 2016, will be achieved through a new manufacturing area. The entire factory, including the existing portion, will be retooled by June 2017, thereby reinforcing the supply structure for the Americas region. Going forward, Sysmex will continue providing a stable supply of high quality products to its customers as it aims to contribute to the health of people around the world.

Sysmex Corp., Q1 2016 Pre Recorded Earnings Call, Aug 05, 2015

Sysmex Corp., Q1 2016 Pre Recorded Earnings Call, Aug 05, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6869:JP ¥6,070.00 JPY -100.00

6869 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $47.29 USD -0.57
Bio-Rad Laboratories Inc $138.63 USD +1.72
BioMerieux €94.43 EUR +0.43
PerkinElmer Inc $47.88 USD +0.35
Shimadzu Corp ¥1,681 JPY +27.00
View Industry Companies

Industry Analysis


Industry Average

Valuation 6869 Industry Range
Price/Earnings 47.0x
Price/Sales 5.8x
Price/Book 7.8x
Price/Cash Flow 41.8x
TEV/Sales 5.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYSMEX CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at